201 related articles for article (PubMed ID: 23918832)
1. Prognostic role of lemur tyrosine kinase-3 germline polymorphisms in adjuvant gastric cancer in Japan and the United States.
Wakatsuki T; LaBonte MJ; Bohanes PO; Zhang W; Yang D; Azuma M; Barzi A; Ning Y; Loupakis F; Saadat S; Volz N; Stintzing S; El-Khoueiry R; Koizumi W; Watanabe M; Shah M; Stebbing J; Giamas G; Lenz HJ
Mol Cancer Ther; 2013 Oct; 12(10):2261-72. PubMed ID: 23918832
[TBL] [Abstract][Full Text] [Related]
2. High expression of LMTK3 is an independent factor indicating a poor prognosis in estrogen receptor α-positive breast cancer patients.
Asano T; Sato S; Yoshimoto N; Endo Y; Hato Y; Dong Y; Takahashi S; Fujii Y; Toyama T
Jpn J Clin Oncol; 2014 Oct; 44(10):889-97. PubMed ID: 25163465
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of lemur tyrosine kinase 3 in postoperative gastric cancer.
Li Z; Wu J; Ji M; Shi L; Xu B; Jiang J; Wu C
Mol Clin Oncol; 2014 Sep; 2(5):756-760. PubMed ID: 25054042
[TBL] [Abstract][Full Text] [Related]
4. The lncRNA MIR2052HG regulates ERα levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1.
Cairns J; Ingle JN; Kalari KR; Shepherd LE; Kubo M; Goetz MP; Weinshilboum RM; Wang L
Breast Cancer Res; 2019 Apr; 21(1):47. PubMed ID: 30944027
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of the c-MET polymorphism on the clinical outcome in locoregional gastric cancer patients.
Sunakawa Y; Wakatsuki T; Yang D; Zhang W; Ning Y; Stintzing S; Stremitzer S; Yamauchi S; Sebio A; El-khoueiry R; Iqbal S; Barzi A; Gerger A; Stotz M; Azuma M; Watanabe M; Koizumi W; Lenz HJ
Pharmacogenet Genomics; 2014 Dec; 24(12):588-96. PubMed ID: 25203738
[TBL] [Abstract][Full Text] [Related]
6. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy.
Lei J; Rudolph A; Moysich KB; Rafiq S; Behrens S; Goode EL; Pharoah PP; Seibold P; Fasching PA; Andrulis IL; Kristensen VN; Couch FJ; Hamann U; Hooning MJ; Nevanlinna H; Eilber U; Bolla MK; Dennis J; Wang Q; Lindblom A; Mannermaa A; Lambrechts D; García-Closas M; Hall P; Chenevix-Trench G; Shah M; Luben R; Haeberle L; Ekici AB; Beckmann MW; Knight JA; Glendon G; Tchatchou S; Alnæs GI; Borresen-Dale AL; Nord S; Olson JE; Hallberg E; Vachon C; Torres D; Ulmer HU; Rüdiger T; Jager A; van Deurzen CH; Tilanus-Linthorst MM; Muranen TA; Aittomäki K; Blomqvist C; Margolin S; Kosma VM; Hartikainen JM; Kataja V; Hatse S; Wildiers H; Smeets A; Figueroa J; Chanock SJ; Lissowska J; Li J; Humphreys K; Phillips KA; ; Linn S; Cornelissen S; van den Broek SA; Kang D; Choi JY; Park SK; Yoo KY; Hsiung CN; Wu PE; Hou MF; Shen CY; Teo SH; Taib NA; Yip CH; Ho GF; Matsuo K; Ito H; Iwata H; Tajima K; Dunning AM; Benitez J; Czene K; Sucheston LE; Maishman T; Tapper WJ; Eccles D; Easton DF; Schmidt MK; Chang-Claude J
Breast Cancer Res; 2015 Feb; 17(1):18. PubMed ID: 25849327
[TBL] [Abstract][Full Text] [Related]
7. Germline polymorphisms in genes involved in the CD44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinoma.
Winder T; Ning Y; Yang D; Zhang W; Power DG; Bohanes P; Gerger A; Wilson PM; Lurje G; Tang LH; Shah M; Lenz HJ
Int J Cancer; 2011 Sep; 129(5):1096-104. PubMed ID: 21105049
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor-beta genetic variations and overall survival in patients with locally advanced gastric cancer.
Sunakawa Y; Cao S; Berger MD; Matsusaka S; Yang D; Zhang W; Ning Y; Parekh A; Stremitzer S; Mendez A; Okazaki S; Wakatsuki T; Azuma M; Shimada K; Watanabe M; Koizumi W; Wu AH; Lenz HJ
Pharmacogenomics J; 2017 Jan; 17(1):36-41. PubMed ID: 26503819
[TBL] [Abstract][Full Text] [Related]
9. A retrospective comparative exploratory study on two methylentetrahydrofolate reductase (MTHFR) polymorphisms in esophagogastric cancer: the A1298C MTHFR polymorphism is an independent prognostic factor only in neoadjuvantly treated gastric cancer patients.
Blank S; Rachakonda S; Keller G; Weichert W; Lordick F; Langer R; Springfeld C; Bruckner T; Becker K; Kumar R; Ott K
BMC Cancer; 2014 Feb; 14():58. PubMed ID: 24490800
[TBL] [Abstract][Full Text] [Related]
10. Lemur tyrosine kinase-3 is a significant prognostic marker for patients with colorectal cancer.
Shi H; Li Q; Ji M; Wu J; Li Z; Zheng X; Xu B; Chen L; Li X; Lu C; Tan Y; Wu C; Jiang J
Int J Clin Exp Pathol; 2014; 7(3):1101-7. PubMed ID: 24695631
[TBL] [Abstract][Full Text] [Related]
11. The polymorphisms of TS and MTHFR predict survival of gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy in Chinese population.
Huang ZH; Hua D; Li LH
Cancer Chemother Pharmacol; 2009 Apr; 63(5):911-8. PubMed ID: 18704422
[TBL] [Abstract][Full Text] [Related]
12. Potentially functional variants in the core nucleotide excision repair genes predict survival in Japanese gastric cancer patients.
Li Y; Liu Z; Liu H; Wang LE; Onodera H; Suzuki A; Suzuki K; Wadhwa R; Elimova E; Sudo K; Shiozaki H; Estrella J; Lee JS; Song S; Tan D; Ajani JA; Wei Q
Carcinogenesis; 2014 Sep; 35(9):2031-8. PubMed ID: 24990617
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of FOXF1 polymorphisms in gastric cancer patients.
Matsusaka S; Wu AH; Cao S; Hanna DL; Chin K; Yang D; Zhang W; Ning Y; Stintzing S; Sebio A; Sunakawa Y; Stremitzer S; Yamauchi S; Okazaki S; Berger MD; Parekh A; Miyamoto Y; Mizunuma N; Lenz HJ
Pharmacogenomics J; 2018 Apr; 18(2):262-269. PubMed ID: 28398355
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism of the programmed death-ligand 1 gene is associated with its protein expression and prognosis in gastric cancer.
Wu Y; Zhao T; Jia Z; Cao D; Cao X; Pan Y; Zhao D; Zhang B; Jiang J
J Gastroenterol Hepatol; 2019 Jul; 34(7):1201-1207. PubMed ID: 30353572
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with gastric cancer.
Kim JG; Sohn SK; Chae YS; Cho YY; Bae HI; Yan G; Park JY; Lee MH; Chung HY; Yu W
Ann Oncol; 2007 Jun; 18(6):1030-6. PubMed ID: 17426061
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of multiple genes involved in NER pathway predict prognosis of gastric cancer.
Liu J; Deng N; Xu Q; Sun L; Tu H; Wang Z; Xing C; Yuan Y
Oncotarget; 2016 Jul; 7(30):48130-48142. PubMed ID: 27340861
[TBL] [Abstract][Full Text] [Related]
17. Associations between CYP2A6 polymorphisms and outcomes of adjuvant S-1 chemotherapy in patients with curatively resected gastric cancer.
Jeong JH; Park SR; Ahn Y; Ryu MH; Ryoo BY; Kong SY; Yook JH; Yoo MW; Kim BS; Kim BS; Kang YK
Gastric Cancer; 2017 Jan; 20(1):146-155. PubMed ID: 26715117
[TBL] [Abstract][Full Text] [Related]
18. The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: A systematic review and meta-analysis.
Qian H; Appiah-Kubi K; Wang Y; Wu M; Tao Y; Wu Y; Chen Y
Crit Rev Oncol Hematol; 2018 Jul; 127():15-28. PubMed ID: 29891108
[TBL] [Abstract][Full Text] [Related]
19. Lemur tyrosine kinase-3 (LMTK3) in cancer and evolution.
Stebbing J; Filipović A; Giamas G
Oncotarget; 2011 Jun; 2(6):428-9. PubMed ID: 21680955
[No Abstract] [Full Text] [Related]
20. LMTK3 expression in breast cancer: association with tumor phenotype and clinical outcome.
Stebbing J; Filipovic A; Ellis IO; Green AR; D'Silva TR; Lenz HJ; Coombes RC; Wang T; Lee SC; Giamas G
Breast Cancer Res Treat; 2012 Apr; 132(2):537-44. PubMed ID: 21671015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
